Cargando…
Erratum: Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799110/ https://www.ncbi.nlm.nih.gov/pubmed/36112778 http://dx.doi.org/10.1164/rccm.v206erratum9 |
| _version_ | 1784861046509404160 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9799110 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97991102022-12-30 Erratum: Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial Am J Respir Crit Care Med Erratum American Thoracic Society 2022-12-01 /pmc/articles/PMC9799110/ /pubmed/36112778 http://dx.doi.org/10.1164/rccm.v206erratum9 Text en Copyright © 2022 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail Diane Gern (dgern@thoracic.org). |
| spellingShingle | Erratum Erratum: Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial |
| title | Erratum: Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial |
| title_full | Erratum: Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial |
| title_fullStr | Erratum: Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial |
| title_full_unstemmed | Erratum: Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial |
| title_short | Erratum: Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial |
| title_sort | erratum: anti-granulocyte–macrophage colony–stimulating factor monoclonal antibody gimsilumab for covid-19 pneumonia: a randomized, double-blind, placebo-controlled trial |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799110/ https://www.ncbi.nlm.nih.gov/pubmed/36112778 http://dx.doi.org/10.1164/rccm.v206erratum9 |